HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver
Clinical trial NCT00980239 · COMPLETED
Trial details
- NCT number
- NCT00980239
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2015-08-01
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.